Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Alopecia areata is caused by the immune system attacking hair follicles.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

15-lipoxygenase helps keep skin healthy by reducing inflammation.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Type 2 inflammation helps wound healing by switching immune cells to repair mode.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Leukocyte recruitment is complex but crucial for resolving inflammation and developing effective therapies.

Higher IL-17A levels indicate more severe alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

The CRH/CRH-R1 system might be involved in causing lichen planus.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

UV-B light increases inflammation-related substances in acne-related skin cells.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Sinapic acid may protect skin cells from UV damage and reduce inflammation, making it a promising anti-aging cosmetic ingredient.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.